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EPIDEMIOLOGY/POPULATION SCIENCE
Intrinsic Frequencies of Carotid Pressure 
Waveforms Predict Heart Failure Events
The Framingham Heart Study
Leroy L. Cooper , Jian Rong, Niema M. Pahlevan, Derek G. Rinderknecht, Emelia J. Benjamin , Naomi M. Hamburg ,  
Ramachandran S. Vasan , Martin G. Larson, Morteza Gharib, Gary F. Mitchell
ABSTRACT: Intrinsic frequencies (IFs) derived from arterial waveforms are associated with cardiovascular performance, aging, 
and prevalent cardiovascular disease (CVD). However, prognostic value of these novel measures is unknown. We hypothesized 
that IFs are associated with incident CVD risk. Our sample was drawn from the Framingham Heart Study Original, Offspring, 
and Third Generation Cohorts and included participants free of CVD at baseline (N=4700; mean age 52 years, 55% women). 
We extracted 2 dominant frequencies directly from a series of carotid pressure waves: the IF of the coupled heart and vascular 
system during systole (ω1) and the IF of the decoupled vasculature during diastole (ω2). Total frequency variation (Δω) was 
defined as the difference between ω1 and ω2. We used Cox proportional hazards regression models to relate IFs to incident 
CVD events during a mean follow-up of 10.6 years. In multivariable models adjusted for CVD risk factors, higher ω1 (hazard 
ratio [HR], 1.14 [95% CI], 1.03–1.26]; P=0.01) and Δω (HR, 1.16 [95% CI, 1.03–1.30]; P=0.02) but lower ω2 (HR, 0.87 [95% 
CI, 0.77–0.99]; P=0.03) were associated with higher risk for incident composite CVD events. In similarly adjusted models, 
higher ω1 (HR, 1.23 [95% CI, 1.07–1.42]; P=0.004) and Δω (HR, 1.26 [95% CI, 1.05–1.50]; P=0.01) but lower ω2 (HR, 0.81 
[95% CI, 0.66–0.99]; P=0.04) were associated with higher risk for incident heart failure. IFs were not significantly associated 
with incident myocardial infarction or stroke. Novel IFs may represent valuable markers of heart failure risk in the community. 
(Hypertension. 2021;77:338-346. DOI: 10.1161/HYPERTENSIONAHA.120.15632.) • Data Supplement
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Numerous studies have identified pulse pressure, an indirect but widely available measure of arterial stiff-ness, as a novel cardiovascular disease (CVD) risk 
factor.1–7 Recently, interest has shifted to potential infor-
mation contained within the waveform features. Several 
studies have examined various time-domain measures, 
such as primary wave amplitude, timing of wave reflec-
tion, augmented pressure amplitude, and augmentation 
index.8–11 Some of these features depend on waveform 
calibration (primary wave amplitude or augmented pres-
sure), whereas others are unitless (augmentation index) 
or depend only on timing (reflected wave arrival time).
Intrinsic frequency (IF) method is a systems-
based approach (based on sparse time-frequency 
representation) for the analysis of heart and vascu-
lar function.12,13 The main advantage of this method is 
its independency on waveform calibration.12,13 The IF 
method models the coupled heart-vascular network as 
an object rotating around an artificial origin where the 
angular velocity of the rotations during systole and dias-
tole are the IFs (ω1 and ω2). Mathematically speaking, 
IF method establishes best fit sine waves separately for 
systole and diastole. The corresponding frequency of 
these sine waves represents the IF for each phase of the 
cardiac cycle, with ω1 representing the IF for systole and 
ω2 for diastole. Recently, Pahlevan et al
12,14 extracted the 
2 IFs from existing clinical data and showed that ω1 is 
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in patients with left ventricle (LV) systolic dysfunction. 
Their results indicated that ω2 values were similar among 
younger participants but gradually diverged with age or 
progressive disease states.12,15 In addition, the prior theo-
retical work showed that cardiac pulsatile power reaches 
a minimum at any given arterial stiffness at a heart rate 
where the difference between ω1 and ω2 is zero.
12 Thus, 
it was concluded that the total frequency variation (Δω=
ω1−ω2) may provide an additional novel measure of opti-
mal ventricular vascular coupling and vascular health.12
Although the aforementioned studies provide a proof 
of concept for novel cardiovascular indices, the prognos-
tic values of the novel IF measures (ω1, ω2, and Δω) as 
indicators of cardiovascular health are unknown. Thus, 
we aimed to examine relations of ω1, ω2, and Δω with 
incident CVD in the Framingham Original, Offspring, 
and Third Generation Cohorts. We hypothesized that IF 
measures are associated with increased risk for incident 
adverse CVD outcomes.
METHODS
The present article adheres to the American Heart Association 
Journals’ implementation of the Transparency and Openness 
Promotion Guidelines (available online at http://www.ahajour-
nals.org/content/TOP-guidelines). The procedure for request-
ing data from the Framingham Heart Study can be found at 
https://framinghamheartstudy.org/.
Participants
The sample for the present study was drawn from the Framingham 
Original, Offspring, and Third Generation Cohorts, which have 
been described.16–18 During Original Cohort examination 26 
(1999–2001, N=558), Offspring examination 7 (1998–2001, 
N=3539), and Gen 3 examination 1 (2002–2005, N=4095), 
participants underwent a noninvasive assessment of central 
hemodynamics (successfully obtained in N=293, N=2484, and 
N=3921, respectively, for a total N=6698). Analysis of wave-
forms to extract IF measures was successfully performed in 
5924 (88.4%) of the 6698 participants. Participants were fur-
ther excluded for the following reasons: prevalent CVD (n=206), 
age<35 years (n=981), or missing laboratory or covariate 
data (n=37). For secondary analyses that assessed relations 
between IF measures and aortic stiffness, we further excluded 
participants with missing carotid-femoral pulse wave velocity 
(N=192). All participants provided written informed consent and 
protocols were approved by Boston University Medical Center’s 
Institutional Review Board.
Noninvasive Hemodynamics and Tonometry
Hemodynamic data were acquired as previously described.19 
After a 5-minute rest, participants were studied in the supine 
position. Arterial tonometry with simultaneous electrocardiog-
raphy was obtained from brachial, radial, femoral, and carotid 
arteries using a custom tonometer. Tonometric data were digi-
tized during the primary acquisition and transferred to a core 
laboratory (Cardiovascular Engineering, Inc.) for blinded analy-
ses. Tonometry waveforms were signal-averaged using the 
electrocardiographic R-wave as a fiducial point.19 Cuff systolic 
and diastolic blood pressures obtained at the time of tonom-
etry were used to calibrate the peak and trough of the signal-
averaged brachial pressure waveform. Diastolic blood pressure 
and integrated brachial mean arterial pressure were used to 
calibrate carotid pressure tracings, which represented central 
aortic pressure.20 Carotid-femoral pulse wave velocity was cal-
culated as previously described accounting for parallel trans-
mission in the carotid artery and aortic arch.21
Intrinsic Frequencies
Derivation of IFs from aortic pressure waveforms, the conver-
gence of its algorithm, and its accuracy has been described 
Nonstandard Abbreviations and Acronyms
CVD cardiovascular disease
HF heart failure
HFpEF HF with preserved ejection fraction






• We have shown for the first time the prognostic rela-
tions between novel intrinsic frequencies derived from 
aortic waveforms and incident cardiovascular disease 
outcomes in the community.
What Is Relevant?
• Blood pressure is a well-known risk factor for cardio-
vascular disease; however, recent interest has shifted 
to potential information contained within pressure 
waveforms.
• Assessment of intrinsic frequencies is noninvasive and 
requires only the analysis of a single waveform; there-
fore, translation to the clinic is feasible.
• Since these intrinsic frequencies are only modestly 
correlated with standard risk factors, they are suitable 
as potential biomarkers.
Summary
Intrinsic frequencies are novel cardiovascular health 
indicators that are associated with increased risk for 
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previously.12,22 IF method is a new method (based on the sparse 
time-frequency representation23) for analysis of coupled 
dynamical systems (See Data Supplement for more details).12,24 
IF method models a coupled dynamical system as an object 
rotating around an origin. The angular velocity of the rotation 
is the IF. In its simplest form, a coupled dynamical system is 
composed of 2 systems. One physiological example of a 2-cou-
pled dynamical system is the LV-arterial system. Figure 1 is the 
visualization of the IF concept.25 IF frequencies are operating 
frequencies treating the LV combined with the aorta and the 
remaining peripheral arteries as a coupled dynamical system 
(heart + aortic tree), which is decoupled upon closure of the 
aortic valve.12,14,22 It is well known that sparse time-frequency 
representation based methods, such as IF method, are capable 
of handling nonlinear and nonstationary signals.12,13,23 Using 
the IF method, one can extract 2 IF frequencies (ω1 and ω2) 
from a single arterial blood pressure waveform. The first IF, ω1, 
describes the dynamics of the systolic phase of the cardiac 
cycle where the LV and aorta (vasculature) are a coupled sys-
tem. Therefore, ω1 is dominated by the dynamics of LV systolic 
function.12,14 The second IF, ω2, belongs to the diastolic phase 
when the aorta and vascular branches are decoupled from the 
LV. Hence, ω2 is dominated by the dynamics of the aorta and 
the rest of the arterial system.12,14,15
The IF algorithm is based on an L2-minimization that uses 
a waveform to compute the IF parameters.22 The mathematical 
formulation is as follows:
Minimize p t T a t b t
T T a
: , [( cos sin ]
, [(




0 0 1 1 1 1
0 2 2 2 2 2
2cos sin ] .ω ωt b t c( ) + ( ) − ||
This minimization is subject to periodicity of the wave-
form ( a a T b T1 2 2 2 2= +cos( ) sin( ))ω ω  and continuity at T0 
( a T b T a T b T1 1 0 1 1 0 2 2 0 2 2 0cos( ) sin( ) cos( ) sin( )).ω ω ω ω+ = +  Here, 
χ (a,b) is the indicator function (χ (a,b)=1 if a ≤t≤b and χ (a,b)=0 
otherwise), T0 is the dicrotic notch time (end-systolic time), 
p(t) is the input waveform, and T is the duration of the cardiac 
cycle. A brute-force algorithm was used to solve this nonconvex 
and nonlinear optimization problem resulting from the afore-
mentioned L2 minimization formulation.
12,22 More details about 
the mathematical formulation of IF method, its computational 
procedure, and its convergence/accuracy have been provided 
previously.12,14,22 Using IF algorithm, we were able to compute 
the 2 IFs ω1 (IF of the coupled LV and aorta + its vascular 
branches) and ω2 (IF of the decoupled aorta after the aortic 
valve closes; Figure 2). Since the goal of the IF method is to 
find the best fit dominant (single) frequency during systole and 
diastole (and not to find the best overall fit for the waveform 
data), the fit figure shows how well the first intrinsic mode func-
tions of the IF represent the actual signal. The notch selection 
for IF calculation was performed using an automatic algorithm. 
To find the notch, a first and second derivatives were calculated 
for the pulse. The algorithm then performed first and second 
derivative analysis to determine the location of the notch by 
searching for zero crossings in the first derivative and peaks in 
the second derivative. Figure S1 in the Data Supplement shows 
reconstruction of IF with various values of ω1 and ω2 from par-
ticipants overlaid on top of the original raw carotid pressure. 
Total frequency variation (Δω) was calculated as the difference 
between ω1 and ω2.
12,25
Incident CVD Outcomes
The criteria for CVD outcomes (CVD-related death, myocardial 
infarction, ischemic or hemorrhagic stroke, and heart failure 
[HF]) have been described.26,27 Medical records were obtained 
for physician and hospital visits related to CVD during follow-
up. All outcomes were reviewed by a committee of 3 physician 
investigators and were adjudicated by using a written protocol. 
A separate group of neurologists adjudicated cerebrovascu-
lar outcomes. Follow-up evaluations were performed on data 
acquired through October 17, 2014.
Clinical Evaluation and Covariates
Medical history, physical examination, and electrocardiography 
were performed routinely at each examination.17 Age, sex, use 
of antihypertensive drugs, and smoking (current versus non-
smoker) were assessed via questionnaires. Height and weight 
were assessed during the examination. Heart rate, systolic and 
diastolic blood pressures, and systolic ejection period were 
assessed during tonometry. Serum cholesterol levels were 
measured from a fasting blood test. Criteria for diabetes were 
a fasting glucose ≥126 mg/dL (7.0 mmol/L) or treatment with 
insulin or an oral hypoglycemic agent. Smoking was defined as 
self-reported regular use of cigarettes in the year preceding 
the examination. Body mass index was calculated by dividing 
weight in kilograms by the square of the height in meters.
Figure 1. Intrinsic frequency (IF) 
visualization.
ω1 and ω2 are the intrinsic frequencies 
during systole and diastole, respectively. 
Rs and Rd are the envelopes of intrinsic 
frequencies associated with ω1 and ω2, 
respectively. dθ/dt is the instantaneous 
frequency. θs and θd are the intrinsic 
phases during systole and diastole, 
respectively (see the Data Supplement 
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Statistical Analyses
Characteristics for the study sample were tabulated. We esti-
mated partial correlations to assess associations among the 
novel IFs (ω1, ω2, and Δω) and hemodynamic measures (heart 
rate, systolic ejection period, and systolic and diastolic blood 
pressures) accounting for age, sex, and cohort. We used 
Cox proportional hazards models to assess the associations 
between individual IFs and the time to a first major CVD event. 
We also assessed the associations between individual IFs and 
the time to event for each type of CVD event (HF, myocardial 
infarction, and stroke) separately. We tested the proportional 
hazards assumption by assessing the significance of time-
dependent covariates by creating interactions of each predic-
tor and survival time. Covariates were selected a priori and 
included components of the Framingham risk score28: age, sex, 
cohort, body mass index, systolic blood pressure, diastolic blood 
pressure, total cholesterol, high-density lipoprotein cholesterol, 
smoking, diabetes, and hypertension treatment as well as addi-
tional potential confounders: heart rate and systolic ejection 
period. To determine whether the relations between IFs and 
incident CVD outcomes differed by age (segregated by median 
age) or sex, we included interaction terms for these variables. 
To further illustrate relations between IFs and CVD outcomes, 
IF variables that were significantly related to CVD outcomes 
as continuous variables were categorized into quartiles to con-
struct Kaplan-Meier curves of cumulative probability. Non-CVD 
death was a censoring event; the curves of cumulative prob-
ability were not modified for competing events.
All analyses were performed with SAS version 9.4 for 
Windows (SAS Institute, Cary, NC). Two-tailed P<0.05 were 
considered statistically significant, except for the tests of inter-
action, where P<0.05/48 (Bonferroni-adjusted P=0.001) was 
considered significant.
RESULTS
Study exclusion criteria resulted in a sample of 4700 par-
ticipants (2577 [55%] women) The full age range of our 
sample was 35 to 98 years. Table S1 presents a compar-
ison of baseline characteristics of included and excluded 
participants. Characteristics of the study sample are pre-
sented in Table 1. Our sample was composed of relatively 
healthy individuals with typical smoking but lower preva-
lence of diabetes and hypertension treatment. Table 2 
provides a partial correlation matrix for the novel IF mea-
sures, demographic data, and hemodynamic measures. 
Partial correlation plots between IF values and hemody-
namic measures are presented in Figure S2. Correlations 
between novel IFs and demographic data are presented 
in Table S2. Higher ω1 and Δω but lower ω2 were mod-
estly to moderately correlated to higher heart rate and 
diastolic blood pressure. Lower ω1 and Δω were mod-
erately to strongly correlated to higher systolic ejection 
period. Additionally, correlations between IFs and systolic 
blood pressure were modest.
During follow-up (mean 10.6 years; median 10.8 years), 
we observed CVD events in 371 (7.9%) participants, with 
94 events resulting in death. The most common events 
were myocardial infarction (n=147 [3.1%]), HF (n=152 
[3.2%]), and stroke (n=116 [2.5%]); some participants 
were observed to have multiple CVD outcomes at the time 
of adjudication. Cox proportional hazards models for indi-
vidual IF measures as predictors of incident CVD events 
are presented in Table 3. In multivariable models adjusted 
Figure 2. The intrinsic frequency (IF) reconstruction of a 
carotid pressure waveform.
The piecewise reconstruction of a representative pressure wave from 
a Framingham participant overlaid on top of the original raw carotid 
pressure waveforms (black) in arbitrary units (AU). The portions of 
the reconstructed waveform represented by ω1 and ω2 are shown 
in blue and red, respectively. The location of the dicrotic notch is 
marked by the vertical gray dotted line.
Table 1. Characteristics of the Sample (N=4700)
Variable Value
Clinical measures
 Age, y 52±13
 Women, N (%) 2577 (55)
 Body mass index, kg/m2 26.9±5.0
 Systolic blood pressure, mm Hg 122±18
 Diastolic blood pressure, mm Hg 75±10
 Pulse pressure, mm Hg 53±13
 Mean arterial pressure, mm Hg 91±12
 End-systolic pressure, mm Hg 99±13
 Heart rate, bpm 63±10
 Total cholesterol, mg/dL 196±35
 High-density lipoprotein cholesterol, mg/dL 55±17
 Systolic ejection period, ms 313±25
 Carotid-femoral pulse wave velocity, m/s* 8.7±3.3
 Hypertension treatment, N (%) 994 (21)
 Diabetes, N (%) 229 (5)
 Smoker, N (%) 657 (14)
 Generation 3 exam 1, N (%) 2567 (55)
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for age, sex, cohort, body mass index, systolic blood pres-
sure, diastolic blood pressure, heart rate, total cholesterol, 
high-density lipoprotein cholesterol, smoking, diabetes, and 
hypertension treatment, higher ω1 and Δω but lower ω2 were 
associated with higher risk for incident composite CVD and 
HF events. In contrast, IFs were not significantly associated 
with incident myocardial infarction or stroke. Models further 
adjusted for systolic ejection period were similar (Table S3). 
We did not observe significant effect modification of IF 
relations with events by median age or sex (all Bonferroni-
corrected P>0.001). We present Kaplan-Meier plots for 
incident HF events by IF quartile groups in Figure S3.
DISCUSSION
Principal Findings
In the community-based Framingham Heart Study, we 
investigated relations of novel IFs (ω1, ω2, and Δω) 
derived from carotid waveforms with risk of incident 
CVD outcomes, including composite CVD events, myo-
cardial infarction, stroke, and HF. In multivariable models 
that adjusted for traditional CVD risk factors and heart 
rate, higher ω1 and Δω (the IF of the coupled heart and 
vascular system during systole and the total frequency 
variation, respectively) but lower ω2 (IF of the decoupled 
vasculature during diastole) were associated with higher 
risk for incident composite CVD and HF events. None 
of the IFs were associated with incident myocardial 
infarction or stroke events alone. Our results are con-
sistent with the hypothesis that IFs are cardiovascular 
health indicators that are associated with increased risk 
for HF in the community.
Recent Studies of Waveform Analysis
Novel noninvasive techniques combined with mathemati-
cal models that describe pulsatile pressure and blood 
flow have provided better understanding of cardiovas-
cular pathophysiology and hemodynamics.29–37 To model 
the complex interactions of the heart and systemic circu-
lation, many investigators have relied on Windkessel and 
wave transmission theories, which can provide simplified 
models that explain changes in arterial pressure wave-
forms due to aging and CVD pathologies. Several recent 
studies used models that depend solely on assessment 
and analysis of arterial pressure waves, which pro-
vide parameters that are associated with CVD risk. For 
example, recent population-based studies have derived 
parameters from carotid arterial waveforms using the 
reservoir-wave concept, which separates pressure into 
Windkessel-related (reservoir) and wave-related compo-
nents.30,31 However, some studies have suggested that 
the reservoir-wave concept should be abandoned since 
it introduces error into arterial wave analysis that leads to 
misconceptions that violate physical principles.38,39 Mea-
sures of vascular dysfunction such as excess pressure 
integral, systolic and diastolic time constants, pulse pres-
sure amplification ratio, and wave reflection index were 
associated with incident composite CVD events among 
middle-age and elderly hypertensive patients.30,31,40 In 
addition, Cheng et al32 performed pulse wave analysis 
on central arterial pressure waveforms in 2 large, pop-
ulation-based cohorts and showed that novel mechani-
cal parameters independently predicted CVD mortality 
among presumably healthy participants.32 However, the 
aforementioned studies were inconsistent in their con-
founding adjustment and sample sizes. Recently, we 
investigated the prognostic utility of measures derived 
from a pressure-only Windkessel wave analysis of cen-
tral waveforms in a Framingham sample.36 In traditional 
linear models, Windkessel-derived parameters were not 
related to incident CVD events; however, in modified 
models that accounted for nonlinear pressure-depen-
dence of systolic and diastolic time constants, Windkes-
sel parameters were modestly related to events.36
Although parameters derived from pressure-only Wind-
kessel models may have modest utility for risk prediction 
in the community, they do not consider fully the implica-
tions of wave transmission at finite velocity. Therefore, 
their ability to represent the system dynamics of blood 
flow and pressure accurately is limited. Other methods for 
deriving novel arterial pressure parameters are based on 
frequency- and time-domain methodologies and rely on 
assessment of both pressure and flow for wave separation 
Table 2. Matrix of Pearson Partial Correlation Coefficients 
for Novel Intrinsic Frequencies and Hemodynamic Measures 
(N=4700)























































Top value is partial r adjusted for age, sex, and cohort; bottom value is P 
value in each cell. CFPWV indicates carotid-femoral pulse wave velocity; DBP, 
diastolic blood pressure; ESP, end-systolic pressure; HR, heart rate; MAP, mean 
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analysis. For example, multiple studies have shown a sig-
nificant relation between backward (reflected) wave and 
incident CVD outcome.9,41,42 However, these studies did 
not directly measure central aortic flow but instead relied 
on various modeling assumptions for wave separation. 
Previously, we performed wave separation to assess the 
relative contributions to CVD risk among a comprehen-
sive panel of individual components of mean and pulsatile 
pressure derived from directly measured central pressure 
and flow.37 In the forgoing study, forward pressure wave 
amplitude, but not backward pressure wave amplitude, 
predicted incident events in models that adjusted for tra-
ditional CVD risk factors. Furthermore, primary pressure 
wave amplitude, a pressure-only surrogate for forward 
pressure wave amplitude, was not associated with CVD. 
Thus, these studies emphasize that novel parameters 
derived from central pressure waveforms alone should be 
independent of or account for aortic blood flow.
IFs as Novel Markers of HF Risk
The arterial pressure wave is governed by dynamics 
of the LV, the systemic arteries, and their interactions; 
therefore, the pressure wave contains information about 
these separate systems and their optimum coupling 
during healthy and pathological states. For the heart 
and arterial system, optimum coupling occurs when 
minimum energy is wasted to convert LV systolic ejec-
tion to forward flow and pressure waves in the systemic 
circulation for perfusion. In multivariable-adjusted mod-
els, higher ω1 (the IF of the coupled heart and arterial 
system during systole) and higher Δω (total frequency 
variation) were associated with a higher risk for incident 
HF. Our observation is consistent with the forgoing theo-
retical work, which showed that ω1 was higher among 
a sample of HF patients with systolic dysfunction.12 In 
addition, Pahlevan et al12 observed that Δω was about 
zero among young, healthy participants with ideal ven-
tricular-arterial coupling, but Δω was significantly higher 
among older individuals and among those with prevalent 
HF.12 During systole, the LV-arterial coupled system has 
a dominant frequency about which the instantaneous 
frequency oscillates, which is primarily dominated by 
cardiac function. Both HF with reduced and preserved 
systolic function (HFrEF and HFpEF, respectively) are 
progressive pathological states of aberrant cardiac func-
tion and suboptimum ventricular-arterial coupling asso-
ciated with poor outcomes, including death. In HFrEF, 
arterial elastance is elevated but LV systolic elastance 
is reduced, leading to worse ventricular-arterial coupling. 
For example, Ky et al43 observed that worse ventricular-
arterial coupling (assessed via Ea/Ees) predicted death 
and cardiac hospitalization outcomes among patients 
with HFrEF.43 Unlike HFrEF, which is characterized by 
LV dilation (eccentric remodeling) and systolic dysfunc-
tion, HFpEF is associated with concentric remodel-
ing, myocardial fibrosis, microvascular rarefaction, and 
diastolic dysfunction of the LV. In HFpEF, both arterial 
and ventricular elastances are elevated, which may help 
to preserve ventricular-arterial coupling.44,45 However, 
in chronic HFpEF patients (compared with hyperten-
sives without HF and healthy controls), Borlaug et al46 
observed impaired dynamic ventricular-arterial coupling 
(as assessed by Ea/Ees) during exercise. Our data sug-
gest that elevation of ω1 and Δω precedes HF clinical 
presentation and may represent preclinical markers for 
HF, indicating nascent impaired coupling of the ventric-
ular-arterial system. Although distinct clinical differences 
among HF classifications exist, we did not distinguish 
by severity of HF or between HFrEF or HFpEF events. 
For example, Ho et al47 showed that incident HFpEF and 
HFrEF are preceded by different antecedent risk factors. 
Thus, additional studies should assess the differential 
relations for IFs at different stages and between partici-
pants with and without systolic dysfunction.
After the aortic valve closes, the heart and aorta are 
decoupled, and the dominant frequency is dictated only 
by the dynamics of the arterial system. Thus, ω2 repre-
sents the IF of the decoupled vasculature during diastole. 
In an adjusted multivariable model, lower ω2 was asso-
ciated with higher risk for incident HF. Since the aorta 
is the largest artery and is coupled directly to the LV, it 
dominates the wave dynamics (and pulsatile load) that 
the heart experiences. Pahlevan et al12 observed lower 
ω2 with increasing age among healthy individuals, and 
ω2 was significantly lower among those with hyperten-
sion and peripheral artery disease (compared with healthy 
individuals).12 Taken together, these data suggest that 
Table 3. Individual Intrinsic Frequency Measures as Predictors of Incident CVD Event (N=4700)
IF measure
Composite CVD 
events (N=371); HR 
(LCL–UCL) P value
MI events (N=147); 
HR (LCL–UCL) P value
HF events 
(N=152); HR  
(LCL–UCL) P value
Stroke events 
(N=116); HR  
(LCL–UCL) P value
ω1 1.14 (1.03–1.26) 0.01 1.10 (0.94–1.30) 0.23 1.23 (1.07–1.42) 0.004 1.02 (0.85–1.23) 0.81
ω2 0.87 (0.77–0.99) 0.03 0.89 (0.73–1.08) 0.24 0.81 (0.66–0.99) 0.035 1.02 (0.82–1.27) 0.85
Δω 1.16 (1.03–1.30) 0.02 1.13 (0.94–1.37) 0.20 1.26 (1.05–1.50) 0.013 0.99 (0.81–1.22) 0.94
Hazard ratios (HRs) expressed per 1 SD higher value. Models add intrinsic frequency measures to the covariates individually, one at a time. All models adjusted for 
age, sex, cohort, body mass index, systolic blood pressure, diastolic blood pressure, heart rate, total cholesterol, high-density lipoprotein cholesterol, smoking, diabetes, 
and hypertension treatment. CVD indicates cardiovascular disease; HF, heart failure; HR, hazard ratio; IF, intrinsic frequency; LCL, lower limits of the 95% confidence 
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lower ω2 may indicate early vascular remodeling associ-
ated with age, such as aortic stiffness and hypertension, 
which can elevate exposure of the heart to pressure pul-
satility. Although pulsatile load contributes modestly to the 
total energy of the heart, multiple studies have shown that 
abnormal pulsatile load contributes to the development 
of ventricular remodeling and progression to HF.19,37,48,49 
Future studies should examine relations between IFs and 
excessive pressure pulsatility resulting from abnormal 
blood pressure elevation and arterial stiffness.
Appropriate and accessible clinical tools are impera-
tive for assessment of markers that may inform clinicians 
about prevention, diagnosis, and progression of CVD. 
Deriving well-known hemodynamic measures using time 
and frequency domain methods is clinically challenging 
because it requires both pressure and flow waves directly 
measured at the same site simultaneously. The novel IFs 
presented herein are derived via a direct time-frequency 
signal analysis that requires only one uncalibrated arterial 
pressure waveform.12,50,51 Measurement of carotid pres-
sure via tonometry is noninvasive and easily and safely 
implemented in a clinical setting with relatively inexpen-
sive equipment and modest training. Ventricular-arterial 
coupling can be assessed in the pressure–volume plane 
via analysis of pressure–volume loops. These methods, 
however, are invasive and limited as they do not char-
acterize aspects of ventricular-arterial interactions, such 
as systolic loading sequence, that are clinically relevant 
for individuals at risk of HF or with prevalent HF.52 Thus, 
assessment of IFs is clinically feasible and may provide a 
novel method to assess HF risk.
Strengths and Limitations
Our prospective study is observational with many years 
of follow-up. We included a large, community-based 
sample consisting of men and women derived from a 
longitudinally followed cohort from across 3 generations 
of participants. Contrary to other common impedance 
and wave intensity methods, which require simultane-
ous measurement of pressure and flow waves,50,51 our 
proposed modified sparse time-frequency representa-
tion method (the IF method) requires only a central arte-
rial (carotid) pressure waveform to perform the analysis. 
There are also limitations of our study to consider. We 
did not account for multiple testing; therefore, our inves-
tigation is more susceptible to type-1 error. Finally, our 
findings may not be generalizable to other racial and eth-
nic groups since this sample was comprised primarily of 
white participants of Western European descent.
PERSPECTIVES
We observed that novel IFs derived from central 
carotid waveforms are predictive of incident HF after 
adjustment for traditional CVD risk factors, heart rate, 
and systolic ejection period. Although differences in IFs 
were observed in older individuals and among those with 
prevalent cardiac and vascular dysfunction,12 we have 
shown for the first time the prognostic relation between 
IFs and incident CVD outcomes in a large commu-
nity-based sample that spans the adult age spectrum. 
Assessment of IFs is noninvasive and requires only the 
analysis of a single waveform; therefore, translation to 
a clinical setting is feasible with relatively inexpensive 
equipment and modest training. In addition, since these 
IF measures were only modestly correlated with stan-
dard risk factors, they are suitable as potential biomark-
ers.53 Thus, our observations suggest that these novel IF 
measures could be used as potential early biomarkers to 
stratify individual CVD risk. Current preventive measures 
are targeted toward individuals who are identified as 
high risk based on traditional CVD risk factors; however, 
these algorithms fail to detect many individuals who will 
eventually develop CVD. Identifying this group before 
clinical manifestations and providing earlier detection 
and treatment could reduce CVD mortality and morbidity.
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